Neoadjuvant Treatment
15 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Study of ctDNA as Prognostic Factor on Resectable Stage IIIA NSCLC Patients Treated With Neoadjuvant Treatment (NCT05382052) | Fundación GECP | 2022-06-17 |
| The Efficacy and Safety of Neoadjuvant Low-dose Radiotherapy Combined With Chemoimmunotherapy in Locally Advanced HNSCC (NCT05343325) | Fifth Affiliated Hospital, Sun Yat-Sen University | 2022-03-09 |
| Lenvatinib and Pembrolizumab in Resectable Mucosal Melanoma (NCT04622566) | Peking University Cancer Hospital & Institute | 2020-12-30 |
| Neo-adjuvant Immunochemotheray Versus Neo-adjuvant Chemotherapy for Resectable Esophageal Carcinoma (NCT04280822) | Henan Cancer Hospital | 2020-04-21 |
| A Study of Olaparib Prior to Surgery and Chemotherapy in Ovarian, Primary Peritoneal, and Fallopian Tube Cancer (NCT02489006) | University Health Network, Toronto | 2016-07-19 |
| Preoperative Chemoradiotherapy With Cetuximab in Rectal Cancer (NCT00506844) | National Cancer Center, Korea | 2006-05-01 |
Track Neoadjuvant Treatment automatically
Every clearance here is in the API, with alerts when new ones post.